|
Milestones
- WP1
- Factors affecting the observed rates of invasive pneumococcal
disease
- WP2
- Establishing novel methodology to measure pneumococcal antibodies
- WP3
- Upper respiratory tract carriage and transmission of pneumococci
- WP4
- Modelling of the effects of different vaccination strategies on
Pnc carriage and invasive disease in different populations
- WP5
- The economic impact of different vaccination strategies on invasive
pneumococcal disease
- WP6
- Pnc-EURO project management
Illustration of milestones (pdf 15 kb)
| Tasks marked with green have
been already achieved! |
WP1: Factors affecting the observed rates of invasive pneumococcal
disease
- 4/2001
- Common study protocol completed
- 3/2002
- Report on the observed rates of invasive
Pnc disease
- 7/2002
- Completion of data collection for system attributes
- 11/2002
- The final data sets on invasive Pnc disease delivered
- 2/2003
- Analysis of the representativeness of the data, and estimation
of the actual rates of Pnc disease in connection with WP4
- 5/2003
- Description of the structure of and differences between the surveillance
systems completed
- 11/2003
- Recommendations for development of a Pnc surveillance system
WP2: Establishing novel methodology to measure pneumococcal antibodies
- 11/2002
- Optimised standardised assay developed
- 7/2003
- Completed analysis of serological samples received from earlier
Pnc studies
- 11/2003
- Completed evaluation of correlates of protection
WP3: Upper respiratory tract carriage and transmission of pneumococci
- 1/2001
- Completion of common study protocol
- 3/2001
- Local and national ethical approval obtained
- 5-7/2002
- Local carriage studies completed
- 9/2002
- Completion of laboratory analysis of samples
- 11/2002
- Analyses of the transmission models completed
- 11/2002
- Results of the analyses delivered for modelling
- 11/2003
- Reports on URT carriage and transmission of Pnc in Europe
WP4: Modelling of the effects of different vaccination strategies
on Pnc carriage and invasive disease in different populations
- 5/2002
- Mathematical transmission models formulated
with specific tasks to be achieved
- 11/2002
- Simulation models for Pnc transmission in the population implemented
- 1/2003
- Analyses of the surveillance systems completed, results delivered
to WP1
- 5/2003
- Statistical analyses to derive parameters of the transmission
models completed
- 11/2003
- Evaluation of different vaccination strategies completed
WP5: The economic impact of different vaccination strategies on
invasive pneumococcal disease
- 5/2002
- Report on review of the economics of invasive pneumococcal disease
- 11/2002
- Report of the cost-of-illness study containing country-specific
costs estimates
- 1/2003
- Analyses of the surveillance systems completed, results delivered
to WP1
- 11/2003
- Report of cost-effectiveness and cost-utility studies
WP6: Pnc-EURO project management
- 11/2001 and 11/2002 and 11/2003
- External annual reports 4/2001
- Database established 6/2001
- Web-site established
- 10/2003
- Final report and technology implementation plan (TIP)
- 10/2003
- Co-ordination of the production of publications in high quality
scientific journals
|
Tuija Leino: (09)
47 441
Mannerheimintie 166
00300 Helsinki
|
